203661-71-6 Usage
Uses
Used in Organic Synthesis:
6-Boc-2-oxo-6-aza-spiro[3.4]octane is used as a building block in organic synthesis for the creation of complex molecules. Its unique structure and functional groups make it a versatile component in the assembly of various organic compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 6-Boc-2-oxo-6-aza-spiro[3.4]octane is utilized as a precursor for the development of pharmaceuticals. Its structural features can be exploited to design and synthesize new drug candidates with potential therapeutic applications.
Used in Pharmaceutical Development:
6-Boc-2-oxo-6-aza-spiro[3.4]octane is used as a key intermediate in the synthesis of pharmaceuticals, particularly for the development of novel drugs targeting specific biological pathways or receptors. Its presence in the molecular structure can influence the pharmacokinetic and pharmacodynamic properties of the final drug product.
Used in Chemical Research:
6-Boc-2-oxo-6-aza-spiro[3.4]octane serves as a subject of study in chemical research, where its reactivity, stability, and potential applications are explored. Understanding its properties can lead to the discovery of new reactions or processes that involve this compound.
Used in the Synthesis of Bioactive Molecules:
6-Boc-2-oxo-6-aza-spiro[3.4]octane is employed in the synthesis of bioactive molecules with potential applications in medicine, such as antimicrobial, antiviral, or anticancer agents. Its incorporation into these molecules can enhance their biological activity or selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 203661-71-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,6,6 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 203661-71:
(8*2)+(7*0)+(6*3)+(5*6)+(4*6)+(3*1)+(2*7)+(1*1)=106
106 % 10 = 6
So 203661-71-6 is a valid CAS Registry Number.
203661-71-6Relevant articles and documents
CHEMICAL COMPOUNDS
-
Paragraph 0110-0112, (2021/04/02)
The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the disclosure have activity as Janus kinase (JAK) inhibitors and are useful in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK by administering a compound herein described.
PYRAZOLE COMPOUNDS AS BTK INHIBITORS
-
Page/Page column 24; 25, (2015/09/23)
The present invention encompasses compounds of the formula (I) wherein the groups R1, Cy, and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
-
Paragraph 0113, (2014/03/21)
The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
-
Paragraph 0128; 0129; 0132, (2014/09/29)
The present invention encompasses compounds of the formula (I) wherein the groups X and Cy are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
